Synthesis and Biological Characterization of L-N6-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor
Authors:
- E. Ann HallinanEHE. Ann Hallinan
- Sofya TsymbalovSTSofya Tsymbalov
- Clifford R. DornCDClifford R. Dorn
- Barnett S. PitzeleBPBarnett S. Pitzele
- Donald W. HansenDHDonald W. Hansen
- William M. MooreWMWilliam M. Moore
- Gina M. JeromeGJGina M. Jerome
- Jane R. ConnorJCJane R. Connor
- Linda F. BransonLBLinda F. Branson
- Deborah L. WidomskiDWDeborah L. Widomski
- Yan ZhangYZYan Zhang
- Mark G. CurrieMCMark G. Currie
- 13 March 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (8) , 1686-1689
Abstract
The 5-tetrazole amide of L-N6-(1-iminoethyl)lysine (L-NIL), L-N6-(1-iminoethyl)lysine 5-tetrazole amide (1), has been prepared and evaluated. In contrast to L-NIL, 1 is a stable, nonhygroscopic, crystalline solid. Unlike L-NIL, 1 has minimal inhibitory activity in vitro on human inducible nitric oxide synthase (iNOS). However, it is rapidly converted in vivo to L-NIL and produces dose-dependent inhibition of iNOS in acute and chronic models of inflammation in the rodent with efficacy comparable to L-NIL. In addition, both 1 and L-NIL exhibit significant and comparable in vivo selectivity for the inhibition of iNOS vs endothelial NOS. Doses approximately 80-fold greater than those that inhibited inflammation do not elevate systemic blood pressure. In summary, both the physical properties and the pharmacological profile of 1 make it an ideal molecule for preclinical and clinical studies on the role of selective iNOS inhibitors in mediating inflammatory disease processes.Keywords
This publication has 11 references indexed in Scilit:
- Interactions between the inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) pathways: implications for therapeutic intervention in osteoarthritisOsteoarthritis and Cartilage, 1999
- INHIBITION OF NITRIC OXIDE SYNTHASE AS A POTENTIAL THERAPEUTIC TARGETAnnual Review of Pharmacology and Toxicology, 1999
- Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesisProceedings of the National Academy of Sciences, 1996
- Nitric oxide: a key mediator in the early and late phase of carrageenan‐induced rat paw inflammationBritish Journal of Pharmacology, 1996
- Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edemaEuropean Journal of Pharmacology, 1996
- 2-Iminopiperidine and Other 2-Iminoazaheterocycles as Potent Inhibitors of Human Nitric Oxide Synthase IsoformsJournal of Medicinal Chemistry, 1996
- Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthaseEuropean Journal of Pharmacology, 1995
- L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide SynthaseJournal of Medicinal Chemistry, 1994
- Nitric oxide activates cyclooxygenase enzymes.Proceedings of the National Academy of Sciences, 1993
- Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.Proceedings of the National Academy of Sciences, 1990